RxDoctor Payments Data

Alexandra Piper

Optometrist · Joliet, ILNPI 1720519002

Payments from drug & device makers

$1,115in general payments, 2019–2025

Across 38 payments — averaging $29.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Alcon$365
  • Oyster Point Pharma, Inc.$148
  • Sight Sciences, Inc.$146
  • AbbVie$103
  • Bausch & Lomb Americas Inc.$85
  • Harrow Eye, LLC$57
  • plus $211 from 7 others

What the payments were for

  • Food & beverage$1,09798%
  • Education$182%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,115 in reported general payments places this provider in the 65th percentile of 2,257 optometrist providers in Illinois.

See all optometrist providers in Illinois

Medicare billing

Part B allowed, 2024
$119,313
Medicare patients
399
Services billed
1,515

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
LumiganBimatoprost16$8,603
LotemaxLoteprednol Etabonate16$5,956
Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol13$2,630
Latanoprost167$2,572
Prednisolone Acetate41$2,090
Timolol Maleate78$1,144
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat48$692
ValacyclovirValacyclovir Hcl11$415
Dorzolamide Hcl13$203
Doxycycline Hyclate15$200
ErythromycinErythromycin Base12$144
Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha11$111

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieLumigan$103$8,60316 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 2,257 optometrist providers in Illinois.

Other optometrist in Joliet

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →